These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 12957725
1. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. Kawecka-Jaszcz K, Jankowski P, Pajak A. Int J Cardiol; 2003 Sep; 91(1):15-23. PubMed ID: 12957725 [Abstract] [Full Text] [Related]
2. [Secondary prevention of ischemic heart disease in diabetics in clinical practice]. Pajak A, Jankowski P, Wolfshaut R, Kawecka-Jaszcz K. Pol Arch Med Wewn; 2004 Oct; 112(4):1189-96. PubMed ID: 15773431 [Abstract] [Full Text] [Related]
3. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys. Pajak A, Jankowski P, Kawecka-Jaszcz K, Surowiec S, Wolfshaut R, Loster M, Batko K, Badacz L, Dubiel JS, Grodecki J, Grodzicki T, Maciejewicz J, Mirek-Bryniarska E, Piotrowski W, Smielak-Korombel W, Tracz W. Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766 [Abstract] [Full Text] [Related]
4. Determinants of poor hypertension management in patients with ischaemic heart disease. Jankowski P, Kawecka-Jaszcz K, Bilo G, Pajak A. Blood Press; 2005 Dec; 14(5):284-92. PubMed ID: 16257874 [Abstract] [Full Text] [Related]
5. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99]. Pajak A, Kawecka-Jaszcz K, Jankowski P, Bilo G, Dubiel JS, Maciejewicz J, Piotrowski W, Smielak-Korombel W, Tracz W. Przegl Lek; 2003 Dec; 60(3):136-41. PubMed ID: 14575013 [Abstract] [Full Text] [Related]
6. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period]. Jankowski P, Kawecka-Jaszcz K, Pajak A. Przegl Lek; 2001 Dec; 58 Suppl 6():21-5. PubMed ID: 11873737 [Abstract] [Full Text] [Related]
7. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3. Fonarow GC, French WJ, Parsons LS, Sun H, Malmgren JA. Circulation; 2001 Jan 02; 103(1):38-44. PubMed ID: 11136683 [Abstract] [Full Text] [Related]
8. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease after discharge in 1997-98 and 1999-2000]. Jankowski P, Kawecka-Jaszcz K, Pajak A, Bilo G, Dubiel JS, Maciejewicz J, Piotrowski W, Smielak-Korombel W, Tracz W. Przegl Lek; 2003 Jan 02; 60(3):142-6. PubMed ID: 14575014 [Abstract] [Full Text] [Related]
11. Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative. LaBresh KA, Owen P, Alteri C, Reilly S, Albright PS, Hordes AR, Shaftel PA, Noonan TE, Stoukides CA, Kaul AF. Am J Cardiol; 2000 Feb 10; 85(3A):23A-29A. PubMed ID: 10695704 [Abstract] [Full Text] [Related]
12. Secondary prevention of coronary artery disease in contemporary clinical practice. Jankowski P, Czarnecka D, Wolfshaut-Wolak R, Łysek R, Łukaszewska A, Bogacki P, Grodecki J, Mirek-Bryniarska E, Nessler J, Podolec P, Kawecka-Jaszcz K, Pająk A. Cardiol J; 2015 Feb 10; 22(2):219-26. PubMed ID: 25299500 [Abstract] [Full Text] [Related]
13. Secondary prevention of coronary artery disease in hospital practice over the decade 1996-2006. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and EUROASPIRE III surveys. Jankowski P, Kawecka-Jaszcz K, Pajak A, Surowiec S, Wolfshaut R, Loster M, Badacz L, Dubiel JS, Grodecki J, Grodzicki T, Maciejewicz J, Mirek-Bryniarska E, Piotrowski W, Smielak-Korombel W, Tracz W. Kardiol Pol; 2009 Aug 10; 67(8A):970-7. PubMed ID: 19784901 [Abstract] [Full Text] [Related]
14. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study. García Ruiz FJ, Marín Ibáñez A, Pérez-Jiménez F, Pintó X, Nocea G, Ahumada C, Alemao E, Yin D, REALITY Study Group. Pharmacoeconomics; 2004 Aug 10; 22 Suppl 3():1-12. PubMed ID: 15669149 [Abstract] [Full Text] [Related]
15. Improving lipid evaluation and management in medicare patients hospitalized for acute myocardial infarction. Malach M, Quinley J, Imperato PJ, Wallen M. Arch Intern Med; 2001 Mar 26; 161(6):839-44. PubMed ID: 11268226 [Abstract] [Full Text] [Related]
16. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part II. Secondary prevention of ischaemic heart disease during hospitalization]. Kawecka-Jaszcz K, Jankowski P, Pajak A, Dubiel J, Maciejewicz J, Piotrowski W, Smielak-Korombel W, Tracz W. Przegl Lek; 2001 Mar 26; 58(11):956-63. PubMed ID: 11987835 [Abstract] [Full Text] [Related]
17. Impact of co-morbid mental illness on the diagnosis and management of patients hospitalized for medical conditions in a general hospital. Briskman I, Bar G, Boaz M, Shargorodsky M. Int J Psychiatry Med; 2012 Mar 26; 43(4):339-48. PubMed ID: 23094466 [Abstract] [Full Text] [Related]
18. A national Survey of Acute Myocardial Infarction and Ischaemia (SAMII) in the U.K.: characteristics, management and in-hospital outcome in women compared to men in patients under 70 years. Bowker TJ, Turner RM, Wood DA, Roberts TL, Curzen N, Gandhi M, Thompson SG, Fox KM. Eur Heart J; 2000 Sep 26; 21(17):1458-63. PubMed ID: 10952838 [Abstract] [Full Text] [Related]
19. Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. Hippisley-Cox J, Pringle M, Crown N, Meal A, Wynn A. BMJ; 2001 Apr 07; 322(7290):832. PubMed ID: 11290638 [Abstract] [Full Text] [Related]
20. [LDL-cholesterol in secondary prevention: goal-attainment in patients on lipid-lowering drugs in private practice and in hospitals in Austria (ZIEL)]. Föger B, Patsch JR. Wien Klin Wochenschr; 2011 Jan 07; 123(1-2):21-7. PubMed ID: 21165704 [Abstract] [Full Text] [Related] Page: [Next] [New Search]